Clin2
NCT04873050Possibly a fitRecruiting

Medication and lifestyle plan to bring blood sugar to normal

Pre DiabetesPostpartum Disorder

Treatments studied

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This Phase 4 study looks at how to help women with a recent history of gestational diabetes get their blood sugar back toward normal levels. It likely includes blood-sugar testing and a controlled diet period to see what works best.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
102 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are female, age 18 to 45
  • You had gestational diabetes in your most recent pregnancy, and you are 6 months to 10 years postpartum
  • Your BMI is 25 or higher (in the overweight range)
  • You must not plan pregnancy during the study, and you use reliable birth control (or have had tubal ligation)
  • Your blood sugar test shows “prediabetes range” results (impaired fasting or impaired glucose tolerance)
  • You can follow study rules like keeping your usual activity level and eating a standardized diet before testing

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05569772Recruiting· Phase 3
Semaglutide for prediabetes after gestational diabetes

This trial studies whether semaglutide can help women with prediabetes after past gestational diabetes return to better blood sugar levels and lower progression to diabetes. It is designed for women who are no longer breastfeeding and can use effective birth control.

Aalst
NCT07195994Recruiting
Study of an investigational product with or without semaglutide for blood sugar

This trial tests an investigational product to see how well it controls blood sugar in adults with prediabetes or type 2 diabetes. Some participants will also take the diabetes medication semaglutide to compare effects.

London, Ontario
NCT07430332Not yet recruiting· Phase 2
GLP-1 drug for early stage type 1 diabetes

This trial tests a medicine called a GLP-1 receptor agonist (like Ozempic) to see if it can help people with very early type 1 diabetes (stage 1) keep their insulin-making cells working longer. You may be a good fit if you have stage 1 type 1 diabetes and haven't needed insulin yet.

Cincinnati, Ohio
NCT06387199Recruiting· Phase 2/Phase 3
Weekly semaglutide with closed-loop system for type 1 diabetes

This trial tests whether adding a weekly semaglutide injection (a GLP-1 drug) to a closed-loop insulin system can help reduce the need for carb counting in people with type 1 diabetes. It aims to improve blood sugar control and make diabetes management easier.

Montreal, Quebec
NCT07046273Not yet recruiting· Phase 3
Semaglutide for type 2 diabetes: a phase 3 trial

This trial tests if a new form of semaglutide works as well as the approved drug Ozempic for lowering blood sugar. It's for adults with type 2 diabetes who are already taking metformin and need better sugar control.

NCT07415954Recruiting· Phase 2
Testing a new diabetes medicine for blood sugar control

This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.

Lancaster, California

Hear when a new Pre Diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.